Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)
Status:
Terminated
Trial end date:
2019-03-07
Target enrollment:
Participant gender:
Summary
This study was designed to characterize dose response, and evaluate safety and efficacy of
three different doses of EMA401 compared to placebo in patients with post-herpetic neuralgia
(PHN).